Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Steven Arrigo"'
Autor:
Shaharyar Ahmad, Anthony Ricco, Royce Brown, Alexandra Hanlon, Jun Yang, Jing Feng, Michael Stanley, Richard Buonocore, Aubrey Okpaku, Steven Arrigo, John Lamond, Luther Brady, Rachelle Lanciano
Publikováno v:
Frontiers in Oncology, Vol 7 (2017)
PurposeTo document survival for patients treated with stereotactic radiosurgery (SRS) alone for brain metastases either at initial presentation or for salvage in conjunction with other known prognostic factors in a single institutional community sett
Externí odkaz:
https://doaj.org/article/dbc3b5ec1447443ab7e829165a3be693
Autor:
Jing Feng, John Lamond, A. Lozano, Steven Arrigo, Rachelle Lanciano, A. Ricco, A.L. Hanlon, Jun Yang, M. Good, G. Barbera
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e899-e900
Autor:
John Lamond, A.L. Hanlon, Steven Arrigo, R. Buonocore, L. Brady, D. R. Brown, W. Ding, Jing Feng, M. Stanley, A. Okpaku, Cory Heal, Rachelle Lanciano, Jun Yang
Publikováno v:
Journal of Radiation Oncology
Objective The objective of the present study is to analyze prognostic factors affecting survival of patients receiving stereotactic radiosurgery (SRS) for second brain metastatic event (SBME) following initial treatment with whole brain irradiation (
Autor:
John Lamond, S. Barlow, Jun Yang, J. Jacob, A. Ricco, O. Obayomi-Davies, Steven Arrigo, Jing Feng, Rachelle Lanciano, A.L. Hanlon
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:E583-E584
Autor:
A.L. Hanlon, Steven Arrigo, M. Good, M. Dziemianowicz, A. Ricco, Luther W. Brady, Jing Feng, S.P. Guilday, O. Obayomi-Davies, Jun Yang, John Lamond, Rachelle Lanciano
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:e113-e114
Autor:
Steven Arrigo, Luther W. Brady, Michael Mooreville, Michael Good, Caspian Oliai, Rachelle Lanciano, John Lamond, Jun Yang, Bruce B. Garber, Brian Sprandio
Publikováno v:
Journal of Radiation Oncology
Objective The low alpha/beta ratio of prostate cancer suggests that hypofractionated schemes of dose-escalated radiotherapy should be advantageous. We report our experience using stereotactic body radiation therapy (SBRT) for the primary treatment of
Autor:
A.L. Hanlon, Luther W. Brady, Rachelle Lanciano, Matthew Bernetich, A. Ricco, Steven Arrigo, John Lamond, Jun Yang, G. Manahan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 93:E217
Autor:
John Lamond, Michael Mooreville, Luther W. Brady, Matthew Bernetich, Steven Arrigo, Bruce B. Garber, Caspian Oliai, Rachelle Lanciano, Michael Good, Jun Yang
Publikováno v:
Journal of Clinical Oncology. 33:e16023-e16023
e16023 Background: Stereotactic body radiation therapy (SBRT) is an attractive option for the primary treatment of localized prostate cancer due to favorable treatment duration and cost. Recent ana...
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 81:S354
Autor:
John Lamond, Rachelle Lanciano, Bruce B. Garber, Alexandra L. Hanlon, Michael Good, Michael Mooreville, Jun Yang, Caspian Oliai, Steven Arrigo, Luther W. Brady, Matthew Bernetich
Publikováno v:
Journal of Radiation Oncology
Objective Stereotactic body radiation therapy (SBRT) is an attractive option for prostate cancer due to its short treatment duration and cost. In this report, we compare the efficacy and toxicity outcomes of prostate cancer patients treated with SBRT